ArticleFrontiers in neurology2022

OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBE.

Pinky Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.